BHVN (biohavenpharma.com) Return on Sales by Net Profit

Graphic logo of Biohaven Ltd (BHVN)

Biohaven Ltd. attracts leading neurobiologists through generous funding and stock options, as evidenced by the net operating margin chart. Today 0.00 expresses the value of the metric today. The business seeks to monopolize migraine and epilepsy therapy niches via the Kv7 platform, relying on flexible collaboration with external research centers to conduct final-stage trials.

biohavenpharma.com (BHVN) - Net Return on Sales from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for Biohaven Pharmaceutical (BHVN)

- market value and analyst target forecast:
Summary company analytics:Biohaven, BHVN
Flagship merchandise of Biohaven Ltd

Sales margins determine the share of net profit in every dollar of revenue, allowing for an assessment of cost management efficiency relative to historical cycles. By analyzing the net profit margin trend, an investor can identify risks of stagnation or overpayment, which is critical for Biohaven Ltd. (BHVN) as it develops its pipeline through the licensing of Asian molecules without capital-intensive mergers and acquisitions.

Direct competitors

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Net Sales Margin|AXSM: Net Profit Rate|Net Margin acadia-pharm.com (ACAD)|Net Sales Margin Xenon Pharmaceuticals (XENE)|Net Margin Viking Therapeutics VKTX|Net Profit Rate SUPN|CPRX - Net Margin|Net Margin Denali Therapeutics|HRMY: Net Sales Margin|Net Margin Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Net Sales Margin|Net Return on Sales PRAX (Praxis Medicines)|Net Margin Anavex Life Sciences (AVXL)|Net Margin CBLL (CeriBell EEG)|Net Sales Margin PRTA (Prothena Corp)|alector.com (ALEC) - Net Margin|ANNX: Return on Sales by Net Profit|Net Margin Omeros|NGNE: Net Sales Margin|Return on Sales by Net Profit AC Immune|Return on Sales by Net Profit VYGR|Net Return on Sales NMRA (neumoratx.com)|Return on Sales by Net Profit SCLX (Scilex Holding Company, Inc.)|Net Margin TVGN (Tevogen Bio)|Net Margin Alpha Cognition ACOG|CGTX - Return on Sales by Net Profit|IKT - Net Margin|SAVA: Net Margin|Assertio Therapeutics (ASRT) - Net Margin|Net Margin Coya Therapeutics Inc (COYA)|Net Margin Vistagen|Net Return on Sales OVID (ovidrx.com)|Net Margin Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Net Margin|Alterity Therapeutics Ltd. - Return on Sales by Net Profit|CLNN - Return on Sales by Net Profit|PEPG - Net Margin|Company Sales Margin jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Net Margin|ANVS (Annovis Bio, Inc.) - Net Margin|Net Margin gracetx.com|Net Sales Margin Firefly Neuroscience, Inc.|Net Margin ANEW Medical (KLTO)|NRSN - Net Margin|Net Sales Margin RVPH (Reviva Pharmaceuticals Holdings Inc.)|Company Net Profitability MTVA (metaviatx.com)|NeurAxis Inc. - Net Sales Margin|Company Sales Margin heliusmedical.com HSDT|PASG: Net Sales Margin|Neuphoria - Net Profit Rate|Return on Sales by Net Profit NERV|ATHA: Net Profit Rate|Net Margin Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Net Profit Rate|Net Sales Margin CYCN (cyclerion.com)|Net Profitability Margin Protagenic|KTTA: Return on Sales by Net Profit|Net Profit Rate CRGT (cortigent.com)|ATXI: Net Sales Margin|BCLI (BrainStorm Cell Therapeutics) - Net Margin|CARA (Cara Therapeutics Inc.) - Net Sales Margin|Net Margin CHRO|Return on Sales by Net Profit ELYM (Eliem Therapeutics)|Net Margin ITCI (Intra-Cellular Therapies Inc.)|Net Sales Margin LBPH (Longboard Pharma)|Net Sales Margin Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Net Sales Margin|Net Profit Rate NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Return on Sales by Net Profit|Net Return on Sales SNPX|Return on Sales by Net Profit TRVN|Net Margin VIGL|Net Sales Margin WENA|Company Sales Margin Cerevel